MCP--STRUCTURE, MICROBIAL INTERACTIONS AND FUNCTION
MCP--结构、微生物相互作用和功能
基本信息
- 批准号:6704229
- 负责人:
- 金额:$ 34.65万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1995
- 资助国家:美国
- 起止时间:1995-04-01 至 2006-02-28
- 项目状态:已结题
- 来源:
- 关键词:NeisseriaceaeStreptococcus pyogenesX ray crystallographyactive sitesbiological signal transductioncomplement inhibitorscomplement pathwaydecay accelerating factorfertilitygenetically modified animalslaboratory mousenuclear magnetic resonance spectroscopyphosphorylationprotein structure functionprotein tyrosine kinasetissue /cell cultureyeast two hybrid system
项目摘要
DESCRIPTION (adapted from investigator's abstract): The complement system is
ingeniously designed to prevent infections as well as to process immune
complexes and damaged tissue. Strict control of its activation during innate
and acquired humoral immune responses is critical to minimize damage to host
tissue. Membrane cofactor protein (MCP; CD46) is widely expressed inhibitor of
complement activation at the critical step of C3/C5 convertase generation. It
serves as a cofactor for the serine protease factor I to cleave and thereby
inactivate C3b and C4b that deposit on host tissue. Most cells and tissues
express MCP as a family of four isoforms that differ in their O-glycosylation
and cytoplasmic tails. MCP is a receptor for three human pathogens: measles
virus, Streptococcus pyogenes and Neisseria. Attachment of the measles virus of
Neisseria to MCP transmits signals for IL-12 down-regulation in monocytes or
for calcium fluxes in epithelial cells, respectively. MCP has also been
implicated in reproduction, in large part due to its dense expression on
placental trophoblast and on the inner acrosome membrane of spermatozoa.
Because of its potent complement regulator activity, MCP has been recombinantly
produced for use as a soluble therapeutic agent and engineered into pigs whose
organs are being employed for xenografting. In this grant application, we
propose to continue our studies on the structure, microbial interactions and
function of MCP. We postulated and later demonstrated during the prior grant
period that each of four regularly expressed isoforms of MCP possesses
functional advantages. In this renewal application we continue this focus while
placing an increased emphasis on microbial connections and cell signaling. The
active sites of MCP will be characterized by NMR spectroscopy and X-ray
crystallography. We have recently demonstrated that in three cell types MCP is
tyrosine phosphorylated on one of its two cytoplasmic tails. For this signaling
event, we propose a systematic analysis of the site(s), responsible kinase(s),
and related downstream events. Additionally, we will explore in depth the
microbial interactions with MCP as they relate to binding sites, signaling
events, and three-dimensional structure. We will characterize three strains of
transgenic mice expressing human MCP. We anticipate these animals will be a
valuable tissue source. We also propose a targeted disruption of the MCP mouse
gene since MCP is expressed predominantly on the inner acrosomal membrane of
mouse spermatozoa. The fertility of these mice will be assessed and they will
be crossed with other deficient mice strains to explore the role of MCP in
reproduction. Lastly, the mechanism of action of MCP in situ will be analyzed
by quantitative methods developed during the prior granting period. We will
address such questions as the role of membrane versus fluid phase inhibitors
and contribution of MCP versus decay accelerating factor. The specific aims of
this proposal outline a broad-based approach to increase our understanding of
complement regulation by one if its major inhibitory proteins. Additionally,
these experiments will expand our knowledge of the fascinating interactions of
this complement regulator with three common infectious diseases and its role in
cell signaling events and reproduction.
描述(根据调查员的摘要改编):补充系统是
巧妙地设计以防止感染和处理免疫
复合物和组织受损的组织。严格控制其先天性的激活
并且获得的体液免疫反应对于最大程度地减少对宿主的损害至关重要
组织。膜辅因子蛋白(MCP; CD46)广泛表达的抑制剂
在C3/C5转化酶产生的关键步骤中补体激活。它
用作丝氨酸蛋白酶因子I裂解的辅因子,从而
使沉积在宿主组织上的C3B和C4B失活。大多数细胞和组织
Express MCP作为四个同工型家族,其O-糖基化不同
和细胞质尾巴。 MCP是三种人类病原体的受体:麻疹
病毒,化脓性链球菌和奈瑟氏菌。麻疹病毒的附着
到MCP的奈瑟氏菌在单核细胞中传输IL-12下调的信号
分别用于上皮细胞中的钙通量。 MCP也是
与繁殖有关,在很大程度上是由于其密集的表达
胎盘滋养细胞和精子的内部缩小膜上。
由于其有效的补体调节活性,MCP已重组
用于用作可溶性治疗剂并设计成猪的生产
正在使用器官进行异种。在此赠款申请中,我们
建议继续我们对结构,微生物相互作用和
MCP的功能。我们假设并后来在先前的赠款中证明
四个定期表达的MCP同工型的时期
功能优势。在此续订应用程序中,我们继续关注此重点
越来越重视微生物连接和细胞信号传导。这
MCP的活动位点将以NMR光谱和X射线为特征
晶体学。我们最近证明,在三种细胞类型中,MCP是
酪氨酸在其两个细胞质尾部之一上磷酸化。对于此信号
事件,我们提出了对位点,负责激酶的系统分析,
和相关的下游事件。此外,我们将深入探索
与MCP相关的微生物相互作用与结合位点相关,信号传导
事件和三维结构。我们将表征三种菌株
表达人MCP的转基因小鼠。我们预计这些动物将是
有价值的组织来源。我们还提出了MCP鼠标的目标破坏
基因由于MCP主要表达
鼠标精子。这些小鼠的生育能力将被评估,它们将
与其他缺陷的小鼠菌株交叉以探索MCP的作用
生殖。最后,将分析MCP原位作用机理
通过先前授予期间开发的定量方法。我们将
解决诸如膜与液相抑制剂的作用之类的问题
MCP与衰减加速因子的贡献。具体目的
该建议概述了一种基于广泛的方法,以提高我们对
如果其主要的抑制蛋白补充调节。此外,
这些实验将扩大我们对令人着迷的互动的了解
这种补充调节子具有三种常见的传染病及其在
细胞信号事件和繁殖。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
John Atkinson其他文献
John Atkinson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('John Atkinson', 18)}}的其他基金
Scleroderma Renal Crisis as a Genetic Complementopathy
硬皮病肾危象是一种遗传性互补病
- 批准号:
10159866 - 财政年份:2020
- 资助金额:
$ 34.65万 - 项目类别:
Defining the Complosome in Human Cells, Tissues and Disease States
定义人类细胞、组织和疾病状态中的复合体
- 批准号:
10597611 - 财政年份:2020
- 资助金额:
$ 34.65万 - 项目类别:
Defining the Complosome in Human Cells, Tissues and Disease States
定义人类细胞、组织和疾病状态中的复合体
- 批准号:
10375425 - 财政年份:2020
- 资助金额:
$ 34.65万 - 项目类别:
Complement Activation Signatures in Systemic Lupus Erythematosus: Castle Study
系统性红斑狼疮中的补体激活特征:Castle 研究
- 批准号:
9317177 - 财政年份:2017
- 资助金额:
$ 34.65万 - 项目类别:
Flavivirus NS-1, complement and disease susceptibility
黄病毒 NS-1、补体和疾病易感性
- 批准号:
7672127 - 财政年份:2009
- 资助金额:
$ 34.65万 - 项目类别:
SMALLPOX VIRULENCE AND COMPLEMENT REGULATORY PROTEINS
天花毒力和补体调节蛋白
- 批准号:
7641538 - 财政年份:2008
- 资助金额:
$ 34.65万 - 项目类别:
相似国自然基金
影响Streptococcus pyogenes CRISPR/Cas9脱靶的相关因素及其靶向特异性机制研究
- 批准号:31770069
- 批准年份:2017
- 资助金额:55.0 万元
- 项目类别:面上项目
以肺炎链球菌WalK酶HATPase_c结构域为靶点的新型咪唑类抗菌药物的合成及其抗菌效应研究
- 批准号:81460317
- 批准年份:2014
- 资助金额:48.0 万元
- 项目类别:地区科学基金项目
相似海外基金
MCP--STRUCTURE, MICROBIAL INTERACTIONS AND FUNCTION
MCP--结构、微生物相互作用和功能
- 批准号:
6128387 - 财政年份:1995
- 资助金额:
$ 34.65万 - 项目类别:
CD46: Protecting the Host from Complement Attack
CD46:保护宿主免受补体攻击
- 批准号:
7036880 - 财政年份:1995
- 资助金额:
$ 34.65万 - 项目类别:
MCP--STRUCTURE, MICROBIAL INTERACTIONS AND FUNCTION
MCP--结构、微生物相互作用和功能
- 批准号:
6373459 - 财政年份:1995
- 资助金额:
$ 34.65万 - 项目类别:
MCP--STRUCTURE, MICROBIAL INTERACTIONS AND FUNCTION
MCP--结构、微生物相互作用和功能
- 批准号:
6510589 - 财政年份:1995
- 资助金额:
$ 34.65万 - 项目类别:
MCP--STRUCTURE, MICROBIAL INTERACTIONS AND FUNCTION
MCP--结构、微生物相互作用和功能
- 批准号:
6631888 - 财政年份:1995
- 资助金额:
$ 34.65万 - 项目类别: